The Discounted Cash Flow (DCF) valuation of Inhibrx Inc (INBX) is (320.20) USD. With the latest stock price at 109.27 USD, the upside of Inhibrx Inc based on DCF is -393.0%.
Based on the latest price of 109.27 USD and our DCF valuation, Inhibrx Inc (INBX) is a sell. selling INBX stocks now will result in a potential gain of 393.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.3% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,367.49) - (188.55) | (320.20) |
| Upside | -1351.5% - -272.6% | -393.0% |